Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis

Tumor programmed cell death ligand-1 (PD-L1) expression is a key biomarker to identify patients with non-small cell lung cancer who may have an enhanced response to anti-programmed cell death-1 (PD-1)/PD-L1 treatment. Such treatments are used in conjunction with PD-L1 diagnostic immunohistochemistry...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mod Pathol
Main Authors: Widmaier, Moritz, Wiestler, Tobias, Walker, Jill, Barker, Craig, Scott, Marietta L., Sekhavati, Farzad, Budco, Alexei, Schneider, Katrin, Segerer, Felix J., Steele, Keith, Rebelatto, Marlon C.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group US 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7051919/
https://ncbi.nlm.nih.gov/pubmed/31527709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41379-019-0349-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados